Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03672019 · ClinicalTrials.gov registry record
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage
A clinical trial of Malignant Biliary Obstruction, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 118
- Enrollment target
- 5
- Study locations
NCT03672019 is a study of Malignant Biliary Obstruction that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 118 participants. The trial reports 5 study locations across 2 states.
The verdict
NCT03672019, a study of Malignant Biliary Obstruction, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare the participant's health-related quality of life before and after the biliary drainage procedure. The study will also help us learn whether having a drainage catheter or a stent placed during the procedure makes a difference in the participant's quality of life.
Conditions Studied
Interventions
- BEHAVIORAL FACT-Hep
Study Locations (5)
New York
- Memorial Sloan Kettering Commack (Consent only) - Commack
- Memorial Sloan Kettering Westchester (Consent only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) - Middletown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-09-11 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03672019
The ClinicalTrials.gov registry entry for NCT03672019 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Biliary Obstruction appearing as the primary indexed condition, and to 1 intervention - of which FACT-Hep is the first listed.
NCT03672019 reports 5 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03672019 about?
NCT03672019 is a clinical study titled "A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage". The purpose of this study is to compare the participant's health-related quality of life before and after the biliary drainage procedure. The study will also help us learn whether having a drainage catheter or a stent placed during the procedure makes a difference in the participant's quality of lif...
What is the current status of trial NCT03672019?
This trial is currently active not recruiting. The enrollment target is 118 participants. The study started on 2018-09-11. Estimated completion is 2026-09.
What conditions does trial NCT03672019 study?
This clinical trial studies the following conditions: Malignant Biliary Obstruction.
What interventions are being tested in trial NCT03672019?
The interventions under investigation include: FACT-Hep (BEHAVIORAL).
Who is sponsoring clinical trial NCT03672019?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03672019 being conducted?
This trial has 5 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.